Capnia (NASDAQ:CAPN)

A handheld device for the as-needed treatment of allergic rhinitis

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Capnia (NASDAQ:CAPN) plus 5054 other startups.

Start Free 7 Day Trial Now

Learn More About Capnia (NASDAQ:CAPN)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

Competing Startups

More

Our Clients